Ivabradine for Treatment of Refractory Tachycardia in a Patient With Hypertrophic Cardiomyopathy

Am J Ther. 2018 Nov/Dec;25(6):e690-e692. doi: 10.1097/MJT.0000000000000703.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cardiomyopathy, Hypertrophic / complications*
  • Cardiomyopathy, Hypertrophic / diagnosis
  • Cardiomyopathy, Hypertrophic / drug therapy
  • Cardiovascular Agents / pharmacology
  • Cardiovascular Agents / therapeutic use*
  • Diltiazem / pharmacology
  • Diltiazem / therapeutic use
  • Drug Resistance
  • Echocardiography
  • Electrocardiography
  • Female
  • Humans
  • Ivabradine / therapeutic use*
  • Metoprolol / pharmacology
  • Metoprolol / therapeutic use
  • Middle Aged
  • Tachycardia / diagnosis
  • Tachycardia / drug therapy*
  • Tachycardia / etiology
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • Ivabradine
  • Diltiazem
  • Metoprolol